Provista Diagnostics Receives $2,564,948 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=57ddd2ea-2500-4d58-84de-ecc0a828d803 - Date
10/28/2016 - Company Name
Provista Diagnostics - Mailing Address
55 Broad Street 18th Floor New York, NY 10004 USA - Company Description
Provista Diagnostics, Inc. develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. - Website
http://www.provistadx.com - Transaction Type
Venture Equity, Debt - Transaction Amount
$2,564,948 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
